Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
An alternative more tolerable L-asparaginase variant for the treatment of metastatic breast cancer
Information
Project Team
Organisations
Outputs & Impact
Publications & research data ( 2 )
A human-like glutaminase-free asparaginase is highly efficacious in ASNS-low leukemia and solid cancer mouse xenograft models
Maaike Van Trimpont
Amanda M. Schalk
Kenneth Hofkens
Evelien Peeters
Sara T'Sas
Katrien Vandemeulebroecke
Ying Su
Ashley De Loera
Alyssa Garcia
Hui Chen
et al.
A1
Journal Article
in
CANCER LETTERS
2025
Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy
Maaike Van Trimpont
Evelien Peeters
Yanti De Visser
Amanda M. Schalk
Veerle Mondelaers
Barbara De Moerloose
Arnon Lavie
Tim Lammens
Steven Goossens
Pieter Van Vlierberghe
A1
Journal Article
in
CANCERS
2022
Activities ( 0 )
Results
Impact narratives ( 1 )
Cancer: breasts and ovaries/cervix
Area(s):
Health
Patents ( 0 )